Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ETEST Telavancin (TLA) (0.002-32 ug/mL)

K-Number: K180936 · 2018-07-03

Decision Date2018-07-03
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ETEST Telavancin (TLA) (0.002-32 ug/mL) is a medical device manufactured by Biomerieux S.A.. It received FDA 510(k) clearance on 2018-07-03 under approval number K180936. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ETEST Telavancin (TLA) (0.002-32 ug/mL)?

ETEST Telavancin (TLA) (0.002-32 ug/mL) is a medical device that received FDA 510(k) clearance on 2018-07-03. It is manufactured by Biomerieux S.A.. The 510(k) number is K180936.

When was ETEST Telavancin (TLA) (0.002-32 ug/mL) approved by the FDA?

ETEST Telavancin (TLA) (0.002-32 ug/mL) received FDA 510(k) clearance on 2018-07-03, under approval number K180936.

What company makes ETEST Telavancin (TLA) (0.002-32 ug/mL)?

ETEST Telavancin (TLA) (0.002-32 ug/mL) is manufactured by Biomerieux S.A..

What is the FDA product code for ETEST Telavancin (TLA) (0.002-32 ug/mL)?

The FDA product code for ETEST Telavancin (TLA) (0.002-32 ug/mL) is JWY.

Other Devices by Biomerieux S.A.

View all 10 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.